IO BIOTECH

IOBT Insider Trades:
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-06-05
2025-06-06
GLAUB KATHLEEN SEREDA
A - Grant
Stock Option (Right to Buy)
35,144
$0.00
1
$135.06M
2025-06-05
2025-06-06
HIRTH PETER
A - Grant
Stock Option (Right to Buy)
35,144
$0.00
1
$135.06M
2025-06-05
2025-06-06
HUNTER HEIDI
A - Grant
Stock Option (Right to Buy)
35,144
$0.00
1
$135.06M
2025-06-05
2025-06-06
ELLING CHRISTIAN
A - Grant
Stock Option (Right to Buy)
35,144
$0.00
1
$135.06M
2025-06-05
2025-06-06
SMITH DAVID
A - Grant
Stock Option (Right to Buy)
35,144
$0.00
1
$135.06M
2025-06-05
2025-06-06
COLLINS HELEN LOUISE
A - Grant
Stock Option (Right to Buy)
35,144
$0.00
1
$135.06M
2025-05-30
2025-06-02
HUNTER HEIDI
P - Purchase
Common Stock
15,000
$1.00
15,000
1
$135.06M
2025-04-02
2025-04-04
SULLIVAN AMY
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
215K
$0.00
1
$135.06M
2025-04-02
2025-04-04
AHMAD QASIM IFTIKHAR
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
215K
$0.00
1
$135.06M
2025-04-02
2025-04-04
BURKAVAGE BRIAN
Chief Accounting Officer
A - Grant
Stock Option (Right to Buy)
65,000
$0.00
1
$135.06M
2025-04-02
2025-04-04
SMITH DEVIN WHITTEMORE
General Counsel
A - Grant
Stock Option (Right to Buy)
140K
$0.00
1
$135.06M
2025-04-02
2025-04-04
ZOCCA MAI-BRITT
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
580K
$0.00
1
$135.06M
2024-12-23
2024-12-26
AHMAD QASIM IFTIKHAR
Chief Medical Officer
P - Purchase
Common Stock
31,350
$1.00
31,350
1
$135.06M
2024-12-23
2024-12-23
SMITH DEVIN WHITTEMORE
General Counsel
P - Purchase
Common Stock
12,000
$1.00
12,000
1
$135.06M
2024-12-23
2024-12-23
SULLIVAN AMY
Chief Financial Officer
P - Purchase
Common Stock
10,250
$1.00
10,250
1
$135.06M
2024-12-23
2024-12-23
ZOCCA MAI-BRITT
Chief Executive Officer
P - Purchase
Common Stock
12,500
$1.00
12,500
1
$135.06M
2024-09-11
2024-09-11
NOVO HOLDINGS A/S
S - Sale
-1.00M
$1.00
-1.00M
1
$135.06M
2024-07-26
2024-07-26
NOVO HOLDINGS A/S
S - Sale
COMMON STOCK
-23,478
$1.00
-23,478
1
$135.06M
2024-07-25
2024-07-26
NOVO HOLDINGS A/S
S - Sale
COMMON STOCK
-51,522
$1.00
-51,522
1
$135.06M
2024-07-25
2024-07-25
NOVO HOLDINGS A/S
S - Sale
-75,000
$1.00
-75,000
1
$135.06M
2024-06-06
2024-06-07
SMITH DAVID
A - Grant
Stock Option (Right to Buy)
45,642
$0.00
1
$135.06M
2024-06-06
2024-06-07
COLLINS HELEN LOUISE
A - Grant
Stock Option (Right to Buy)
45,642
$0.00
1
$135.06M
2024-06-06
2024-06-07
ELLING CHRISTIAN
A - Grant
Stock Option (Right to Buy)
45,642
$0.00
1
$135.06M
2024-06-06
2024-06-07
GLAUB KATHLEEN SEREDA
A - Grant
Stock Option (Right to Buy)
45,642
$0.00
1
$135.06M
2024-06-06
2024-06-07
HIRTH PETER
A - Grant
Stock Option (Right to Buy)
45,642
$0.00
1
$135.06M
2024-06-06
2024-06-07
HUNTER HEIDI
A - Grant
Stock Option (Right to Buy)
45,642
$0.00
1
$135.06M
2024-05-10
2024-05-14
NOVO HOLDINGS A/S
S - Sale
COMMON STOCK
-659K
$1.00
-659K
1
$135.06M
2024-03-15
2024-03-18
AHMAD QASIM IFTIKHAR
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
280K
$0.00
1
$135.06M
2024-03-15
2024-03-18
BURKAVAGE BRIAN
Chief Accounting Officer
A - Grant
Stock Option (Right to Buy)
50,000
$0.00
1
$135.06M
2024-03-15
2024-03-18
SMITH DEVIN WHITTEMORE
General Counsel
A - Grant
Stock Option (Right to Buy)
185K
$0.00
1
$135.06M
2024-03-15
2024-03-18
SULLIVAN AMY
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
280K
$0.00
1
$135.06M
2024-03-15
2024-03-18
ZOCCA MAI-BRITT
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
750K
$0.00
1
$135.06M
2024-02-09
2024-02-13
NOVO HOLDINGS A/S
S - Sale
COMMON STOCK
-659K
$2.00
-1.32M
1
$135.06M
2023-11-22
2023-11-24
BURKAVAGE BRIAN
Chief Accounting Officer
P - Purchase
Common Stock
5,000
$1.00
5,000
1
$135.06M
2023-11-21
2023-11-24
BURKAVAGE BRIAN
Chief Accounting Officer
P - Purchase
Common Stock
5,000
$1.00
5,000
1
$135.06M
2023-11-15
2023-11-17
COLLINS HELEN LOUISE
A - Grant
Stock Option (Right to Buy)
64,238
$0.00
1
$135.06M
2023-08-11
2023-08-15
HUNTER HEIDI
A - Grant
Stock Option (Right to Buy)
64,238
$0.00
1
$135.06M
2023-08-09
2023-08-11
ELLING CHRISTIAN
A - Grant
Warrants (Right to Buy)
7.90M
$0.00
1
$135.06M
2023-08-09
2023-08-11
ELLING CHRISTIAN
A - Grant
Common Stock
7.90M
$2.00
16M
1
$135.06M
2023-08-09
2023-08-11
LUNDBECKFOND INVEST A/S
A - Grant
Warrants (Right to Buy)
7.90M
$0.00
1
$135.06M
2023-08-09
2023-08-11
LUNDBECKFOND INVEST A/S
A - Grant
Common Stock
7.90M
$2.00
16M
1
$135.06M
2023-08-09
2023-08-11
NOVO HOLDINGS A/S
P - Purchase
Common Stock Warrant (Right to Buy)
2.47M
$2.00
4.94M
1
$135.06M
2023-08-09
2023-08-11
NOVO HOLDINGS A/S
P - Purchase
Common Stock
2.47M
$2.00
4.94M
1
$135.06M
2023-08-09
2023-08-10
VIVO CAPITAL IX, LLC
P - Purchase
Warrants (Right to Buy)
3.16M
$0.00
1
$135.06M
2023-08-09
2023-08-10
VIVO CAPITAL IX, LLC
P - Purchase
Common Stock
3.16M
$2.00
6.32M
1
$135.06M
2023-08-09
2023-08-09
SMITH DEVIN WHITTEMORE
General Counsel
A - Grant
Warrants (Right to Buy)
4,938
$0.00
1
$135.06M
2023-08-09
2023-08-09
SMITH DEVIN WHITTEMORE
General Counsel
A - Grant
Common Stock
4,938
$2.00
9,876
1
$135.06M
2023-08-09
2023-08-09
SULLIVAN AMY
Chief Financial Officer
A - Grant
Warrants (Right to Buy)
49,382
$0.00
1
$135.06M
2023-08-09
2023-08-09
SULLIVAN AMY
Chief Financial Officer
A - Grant
Common Stock
49,382
$2.00
98,764
1
$135.06M
2023-08-09
2023-08-09
ZOCCA MAI-BRITT
Chief Executive Officer
A - Grant
Warrants (Right to Buy)
37,037
$0.00
1
$135.06M
2023-08-09
2023-08-09
ZOCCA MAI-BRITT
Chief Executive Officer
A - Grant
Common Stock
37,037
$2.00
74,074
1
$135.06M
2023-07-17
2023-07-19
AHMAD QASIM IFTIKHAR
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
288K
$0.00
1
$135.06M
2023-06-08
2023-06-13
ELLING CHRISTIAN
A - Grant
Stock Option (Right to Buy)
41,533
$0.00
1
$135.06M
2023-06-08
2023-06-13
GLAUB KATHLEEN SEREDA
A - Grant
Stock Option (Right to Buy)
41,533
$0.00
1
$135.06M
2023-06-08
2023-06-13
HIRTH PETER
A - Grant
Stock Option (Right to Buy)
41,533
$0.00
1
$135.06M
2023-06-08
2023-06-13
NIELSEN JACK
A - Grant
Stock Option (Right to Buy)
41,533
$0.00
1
$135.06M
2023-06-08
2023-06-13
SMITH DAVID
A - Grant
Stock Option (Right to Buy)
41,533
$0.00
1
$135.06M
2023-03-20
2023-03-22
ZOCCA MAI-BRITT
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
500K
$0.00
1
$135.06M
2023-03-20
2023-03-22
AL-HAJJ MUHAMMAD
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
120K
$0.00
1
$135.06M
2023-03-20
2023-03-22
BURKAVAGE BRIAN
Chief Accounting Officer
A - Grant
Stock Option (Right to Buy)
50,000
$0.00
1
$135.06M
2023-03-20
2023-03-22
EHRNROOTH EVA
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
120K
$0.00
1
$135.06M
2023-03-20
2023-03-22
SULLIVAN AMY
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
55,000
$0.00
1
$135.06M
2023-03-17
2023-03-20
SULLIVAN AMY
Chief Financial Officer
P - Purchase
Common Stock
25,000
$2.00
50,000
1
$135.06M
2023-01-12
2023-01-13
SMITH DEVIN WHITTEMORE
General Counsel
A - Grant
Stock Option (Right to Buy)
150K
$0.00
1
$135.06M
2022-10-17
2022-10-19
SULLIVAN AMY
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
288K
$0.00
1
$135.06M
2022-05-31
2022-06-02
BURKAVAGE BRIAN
Chief Accounting Officer
A - Grant
Stock Option (Right to Buy)
20,000
$0.00
1
$135.06M
2022-05-26
2022-05-31
ELLING CHRISTIAN
A - Grant
Stock Option (Right to Buy)
23,885
$0.00
1
$135.06M
2022-05-26
2022-05-31
GLAUB KATHLEEN SEREDA
A - Grant
Stock Option (Right to Buy)
23,885
$0.00
1
$135.06M
2022-05-26
2022-05-31
HIRTH PETER
A - Grant
Stock Option (Right to Buy)
23,885
$0.00
1
$135.06M
2022-05-26
2022-05-31
NIELSEN JACK
A - Grant
Stock Option (Right to Buy)
23,885
$0.00
1
$135.06M
2022-05-26
2022-05-31
SMITH DAVID
A - Grant
Stock Option (Right to Buy)
23,885
$0.00
1
$135.06M
2022-03-01
2022-03-03
SMITH DAVID
A - Grant
Stock Option (Right to Buy)
28,019
$0.00
1
$135.06M
2021-11-09
2021-11-12
ANDERSSON CLAUS
C - Conversion
Series B Preferred Stock
-148K
$0.00
1
$135.06M
2021-11-09
2021-11-12
ANDERSSON CLAUS
C - Conversion
Series C Preferred Stock
-28,225
$0.00
1
$135.06M
2021-11-09
2021-11-12
ANDERSSON CLAUS
C - Conversion
Common Stock
1.72M
2
$135.06M
2021-11-09
2021-11-12
HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.
C - Conversion
Series C Preferred Stock
-188K
$0.00
1
$135.06M
2021-11-09
2021-11-12
ANDERSSON CLAUS
P - Purchase
Common Stock
75,000
$14.00
1.05M
1
$135.06M
2021-11-09
2021-11-12
HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.
P - Purchase
Common Stock
325K
$14.00
4.55M
1
$135.06M
2021-11-09
2021-11-12
LUNDBECKFOND INVEST A/S
P - Purchase
Common Stock
2.14M
$14.00
30M
1
$135.06M
2021-11-09
2021-11-12
MALIER VANESSA
P - Purchase
Common Stock
325K
$14.00
4.55M
2
$135.06M
2021-11-09
2021-11-12
NIELSEN JACK
P - Purchase
Common Stock
650K
$14.00
9.10M
1
$135.06M
2021-11-09
2021-11-12
VIVO CAPITAL IX, LLC
P - Purchase
Common Stock
650K
$14.00
9.10M
1
$135.06M
2021-11-09
2021-11-12
HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.
C - Conversion
Common Stock
2.37M
1
$135.06M
2021-11-09
2021-11-12
LUNDBECKFOND INVEST A/S
C - Conversion
Series B Preferred Stock
-220K
$0.00
1
$135.06M
2021-11-09
2021-11-12
LUNDBECKFOND INVEST A/S
C - Conversion
Series C Preferred Stock
-151K
$0.00
1
$135.06M
2021-11-09
2021-11-12
LUNDBECKFOND INVEST A/S
C - Conversion
Common Stock
3.91M
2
$135.06M
2021-11-09
2021-11-12
MALIER VANESSA
C - Conversion
Series C Preferred Stock
-84,675
$0.00
2
$135.06M
2021-11-09
2021-11-12
MALIER VANESSA
C - Conversion
Common Stock
1.06M
2
$135.06M
2021-11-09
2021-11-12
NIELSEN JACK
C - Conversion
Series C Preferred Stock
-188K
$0.00
1
$135.06M
2021-11-09
2021-11-12
NIELSEN JACK
C - Conversion
Common Stock
2.37M
1
$135.06M
2021-11-09
2021-11-12
VIVO CAPITAL IX, LLC
C - Conversion
Series C Preferred Stock
-188K
$0.00
1
$135.06M
2021-11-09
2021-11-12
VIVO CAPITAL IX, LLC
C - Conversion
Common Stock
2.37M
1
$135.06M
2021-11-09
2021-11-12
ZOCCA MAI-BRITT
Chief Executive Officer
C - Conversion
Class A Stock
-26,580
$0.00
1
$135.06M
2021-11-09
2021-11-12
ZOCCA MAI-BRITT
Chief Executive Officer
C - Conversion
Common Stock
26,580
1
$135.06M
2021-11-09
2021-11-10
NOVO HOLDINGS A/S
C - Conversion
SERIES B CONVERTIBLE PREFERRED STOCK
-217K
1
$135.06M
2021-11-09
2021-11-10
NOVO HOLDINGS A/S
C - Conversion
SERIES C CONVERTIBLE PREFERRED STOCK
-75,267
1
$135.06M
2021-11-09
2021-11-10
NOVO HOLDINGS A/S
C - Conversion
COMMON STOCK
2.95M
1
$135.06M
2021-11-09
2021-11-10
NOVO HOLDINGS A/S
P - Purchase
COMMON STOCK
325K
$14.00
4.55M
1
$135.06M
2021-11-04
2021-11-08
GLAUB KATHLEEN SEREDA
A - Grant
Stock Option (Right to Buy)
21,295
$0.00
1
$135.06M
2021-11-04
2021-11-08
HIRTH PETER
A - Grant
Stock Option (Right to Buy)
34,731
$0.00
1
$135.06M
2021-11-04
2021-11-08
VENDOLA KEITH
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
69,469
$0.00
1
$135.06M
2021-11-04
2021-11-08
ZOCCA MAI-BRITT
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
414K
$0.00
1
$135.06M